CStone Pharmaceuticals (FRA:PH4)
Germany · Delayed Price · Currency is EUR 0.5800
-0.0050 (-0.85%)
Last updated: Jan 28, 2026, 3:25 PM CET
CStone Pharmaceuticals Revenue
CStone Pharmaceuticals had revenue of 49.45M CNY in the half year ending June 30, 2025, a decrease of -81.09%. This brings the company's revenue in the last twelve months to 202.49M, down -55.65% year-over-year. In the year 2024, CStone Pharmaceuticals had annual revenue of 407.21M, down -12.21%.
Revenue (ttm)
202.49M CNY
Revenue Growth
-55.65%
P/S Ratio
35.40
Revenue / Employee
1.55M CNY
Employees
131
Market Cap
852.14M EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 407.21M | -56.64M | -12.21% |
| Dec 31, 2023 | 463.84M | -17.52M | -3.64% |
| Dec 31, 2022 | 481.36M | 237.65M | 97.51% |
| Dec 31, 2021 | 243.72M | -795.11M | -76.54% |
| Dec 31, 2020 | 1.04B | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paul Hartmann AG | 2.44B |
| FRoSTA Aktiengesellschaft | 652.00M |
| tonies SE | 510.38M |
| Maschinenfabrik Berthold Hermle AG | 469.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Northern Data AG | 200.27M |
| Berliner Effektengesellschaft AG | 174.56M |